1. |
Risk factors* |
|
2. |
Type/pattern of anti-diabetic treatment, insulin use and other therapies |
Anti-diabetic therapy ever;40 Therapies with cardiovascular benefits versus other; Changes in drug treatments;43 or the number of prescribed treatments42
Insulin use: prescription ever or within 1 year of diagnosis; Insulin initiation:15 time to initiation
Other therapies: ACE inhibitors (ACEI) and lipid-regulating therapies
|
3. |
Diabetes-related microvascular complications15 34
|
Neuropathy (foot ulcer, Charcot foot, gangrene, amputation)
Nephropathy
Retinopathy (laser therapy and blindness)
|
4. |
Renal disease |
Microalbuminuria and proteinuria
Moderate-severe chronic kidney disease (CKD) stages 3 and 434
End-stage renal disease (ESRD): kidney transplant and dialysis
|
5. |
Cardiovascular and cerebrovascular disease |
Atherosclerosis15 34
Myocardial infarction (MI)15 34
Angina15 34
Atrial/ventricular fibrillation (AF)/(VF)34
Heart valve disease
Heart failure (HF)34
Peripheral vascular disease (PVD)34
Transient ischaemic attack (TIA)
Ischaemic stroke, haemorrhagic stroke15 34
|
6. |
Cardiovascular and cerebrovascular interventions |
Coronary artery bypass graft (CABG)
Coronary artery interventions (PCI/PTCA)
Endovascular aneurysm repair (EVAR)
PVD stenting and bypass procedures
Heart valve interventions
Use of defibrillator
Carotid artery events, stenting and bypass interventions
|
7. |
Other comorbidities |
Anxiety
Depression
Dementia
Cognitive impairment
|
8. |
Hospital admissions |
Any-cause hospital admissions
Diabetes-attributable admission
Cardiovascular disease-related admission
|
9. |
Emergency diabetes-related events |
|